Terms: = Breast cancer AND TPM3, ENSG00000143549, 7170
18 results:
1. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C
Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356
[TBL] [Abstract] [Full Text] [Related]
2. The role of miR-223 in breast cancer; an integrated analysis.
Sahin Y; Altan Z; Karabulut A; Saadat KASM; Arslan A
Mol Biol Rep; 2023 Dec; 50(12):10179-10188. PubMed ID: 37924447
[TBL] [Abstract] [Full Text] [Related]
3. Incidence of cancer and Role of Sentinel Lymph Node Biopsy in BRCA Mutation Carriers Undergoing Prophylactic Mastectomies.
Fat SC; Weed C; Samaha Y; Chung A; Boyle MK; Giuliano A; Ray E; Amersi F
Am Surg; 2023 Oct; 89(10):4066-4071. PubMed ID: 37184070
[TBL] [Abstract] [Full Text] [Related]
4. Gene Expression Behavior of a Set of Genes in Platelet and Tissue Samples from Patients with breast cancer.
Burciaga-Hernandez LA; Cueto-Villalobos CF; Ortega-Piñon N; Gonzalez-Curiel IE; Godina-Gonzalez S; Mendez-Frausto G; Aguilar-Esquivel AP; Maldonado-Lagunas V; Guerrero-de la Torre LE; Melendez-Zajgla J; Sanchez-Garcia EK; Mitre-Aguilar IB; Mendoza-Almanza G
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176055
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the Treatment of Androgen Receptor-positive Prostate and breast cancers.
Tien AH; Sadar MD
Mol Cancer Ther; 2022 Feb; 21(2):294-309. PubMed ID: 34815359
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic breast cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract] [Full Text] [Related]
7. Delivery of platelet tpm3 mRNA into breast cancer cells via microvesicles enhances metastasis.
Yao B; Qu S; Hu R; Gao W; Jin S; Ju J; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2159-2169. PubMed ID: 31705785
[TBL] [Abstract] [Full Text] [Related]
8. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of cancers with NTRK gene fusions.
Gatalica Z; Xiu J; Swensen J; Vranic S
Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
[TBL] [Abstract] [Full Text] [Related]
10. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan.
Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Kakeda K; Uchitomi Y; Yamada N
Cancer; 2018 Feb; 124(3):555-562. PubMed ID: 29076156
[TBL] [Abstract] [Full Text] [Related]
11. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
[TBL] [Abstract] [Full Text] [Related]
12. Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.
Dube S; Thomas A; Abbott L; Benz P; Mitschow C; Dube DK; Poiesz BJ
Oncol Rep; 2016 Jun; 35(6):3143-50. PubMed ID: 27108600
[TBL] [Abstract] [Full Text] [Related]
13. Comparative Proteomics of Tumor and Paired Normal breast Tissue Highlights Potential Biomarkers in breast cancer.
Da Costa GG; Gomig TH; Kaviski R; Santos Sousa K; Kukolj C; De Lima RS; De Andrade Urban C; Cavalli IJ; Ribeiro EM
Cancer Genomics Proteomics; 2015; 12(5):251-61. PubMed ID: 26417028
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis.
Singleton DC; Rouhi P; Zois CE; Haider S; Li JL; Kessler BM; Cao Y; Harris AL
Oncogene; 2015 Sep; 34(36):4713-22. PubMed ID: 25486436
[TBL] [Abstract] [Full Text] [Related]
15. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
[TBL] [Abstract] [Full Text] [Related]
16. From morphological to molecular diagnosis of soft tissue tumors.
Miettinen M
Adv Exp Med Biol; 2006; 587():99-113. PubMed ID: 17163160
[TBL] [Abstract] [Full Text] [Related]
17. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract] [Full Text] [Related]
18. Post-surgery radiation in early breast cancer: survival analysis of registry data.
Vinh-Hung V; Burzykowski T; Van de Steene J; Storme G; Soete G
Radiother Oncol; 2002 Sep; 64(3):281-90. PubMed ID: 12242116
[TBL] [Abstract] [Full Text] [Related]
